View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Carfilzomib (20/70) / Daratumumab (8/8/16) / Dexamethasone (20/20), Multiple Myeloma, Cycle 1
Protocol-ID: 1438 V1.1 (Mini), CARF(20/70)/DRTM(8/8/16)/DEXA(20/20), MM, C1Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.04.2021